SEC filing data SEC EDGAR DEF 14A

NewAmsterdam Pharma Co N.V. CEO pay ratio

SEC EDGAR DEF 14A company record · Chemicals & Pharmaceuticals - structured pay-ratio figures are incomplete for this issuer.

Chemicals & Pharmaceuticals peers All rankings
State
P7
Filing date
n/a
Industry
Chemicals & Pharmaceuticals
Fiscal year
n/a

Data updated August 2026

Subscribe to NewAmsterdam Pharma Co N.V. CEO pay filing updates (RSS)

Structured pay-ratio dollars are incomplete for this CIK. Browse peers via rankings or the industry directory.

Answer first

NewAmsterdam Pharma Co N.V. is tracked in PlainCEOPay's SEC EDGAR DEF 14A corpus with an incomplete latest pay-ratio extraction (missing CEO total or median-worker pay). Its SIC peers in Chemicals & Pharmaceuticals show a median ratio of 42:1 across 168 FY2025 filers.

Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Pay ratio
n/a
Incomplete filing
CEO total
n/a
Summary Compensation Table total
Median worker
n/a
Dodd-Frank median employee

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

Company Info

CIK
1936258
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
P7
View SEC filings →
SEC EDGAR DEF 14A for CIK 1936258. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. NewAmsterdam Pharma Co N.V. is in the DEF 14A corpus without a complete latest pay-ratio extraction.

Read with NewAmsterdam Pharma Co N.V.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps UNFILED · UNFILED · UNFILED.

Chemicals & Pharmaceuticals benchmark

NewAmsterdam Pharma Co N.V. stamps UNFILED · UNFILED · UNFILED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · UNFILED

See where UNFILED · UNFILED packages sit on the national leaderboard after reading NewAmsterdam Pharma Co N.V..
Pay-equity trends · UNFILED

NewAmsterdam Pharma Co N.V.'s UNFILED · UNFILED stamps sit mid-band - pay-equity trends place the ratio against workforce pay.
Data sourced from SEC EDGAR DEF 14A for NewAmsterdam Pharma Co N.V. (CIK 1936258). See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.